Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Supernus Pharmaceuticals (SUPN) Q1 2024 Earnings
SUPN
27
Feb
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.29
-0.01
0.28
0.56
Details
Expected EPS
0.56
Actual EPS
0.02
Surprise EPS
-0.54
Surprise Percent
+96.43%
Description
Supernus Pharmaceuticals (SUPN) has reported earnings of 0.02 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login